Quantcast

Latest Bristol-Myers Squibb Stories

2014-04-01 00:21:53

SAN DIEGO, March 31, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento), a late-stage clinical oncology company developing new treatments for cancer and associated pain, today announced that the first patient has been dosed in the pivotal clinical trial designed to support approval of Cynviloq for the treatment of metastatic breast cancer and non-small cell lung cancer. The registration trial referred to as TRIBECA(TM) (TRIal designed to evaluate BioEquivalence...

2014-03-31 12:28:46

Innovative Physician Executive Brings Breadth of Healthcare Experience LOS ANGELES, March 31, 2014 /PRNewswire/ -- Health economics and policy authority Precision Health Economics (PHE) announced today the hiring of Ross Maclean as chief operating officer (COO). Dr. Maclean's significant and varied background spans the provider, payer, and manufacturing worlds in multiple countries, encompassing leadership skills, management talents, and a rapid career progression. His well-rounded...

2014-03-28 12:26:07

DUBLIN, March 28, 2014 /PRNewswire/ -- Dublin - Research and Markets ( http://www.researchandmarkets.com/research/cw7xqm/investigation) has announced the addition of the "Investigation Report on China's Aripiprazole Market, 2009-2018" [http://www.researchandmarkets.com/research/cw7xqm/investigation ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Schizophrenia is a common mental disorder. Data shows that mental illness has...

2014-03-27 12:29:54

DUBLIN, Mar. 27, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/h3fr9g/global ) has announced the addition of the "Global Pharmaceutical & Biotechnology Outlook 2014: Major US and EU" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) Strategy Diversification Divested: Productivity measurements, divestment of non-core assets resulting in healthy cash position. This will accelerate the next wave of targeted...

2014-03-26 12:29:47

LONDON, March 26, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Global Gynecological Cancers Market 2014-2018 TechNavio's analysts forecast the Global Gynecological Cancers market to grow at a CAGR of 12.47 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increase in prevalence of gynecological cancer. The Global Gynecological Cancers market has also been witnessing the emergence of personalized...

2014-03-21 16:23:29

NEW YORK, March 21, 2014 /PRNewswire/ -- Pomerantz LLP has filed a class action lawsuit against The Medicines Company ("Medicines" or the "Company") (NASDAQ: MDCO) and certain of its officers. The class action, filed in United States District Court, District of New Jersey, and docketed under 2:33-av-00001, is on behalf of a class consisting of all persons or entities who purchased or otherwise acquired Medicines securities between February 20, 2013 and February 12, 2014 both dates...

2014-03-19 16:23:55

BUFFALO, N.Y., March 19, 2014 /PRNewswire/ -- Kinex Pharmaceuticals announced today to having received regulatory and ethics approvals to initiate the first clinical study of an oral form of paclitaxel (Oraxol) in Dunedin Hospital in Otago, New Zealand. This is the first clinical study of Oraxol in New Zealand. Oraxol is also currently in clinical studies conducted in Korea and in the United States of America. Dr. Rudolf Kwan, Chief Medical Officer of Kinex stated "Kinex is...

2014-03-19 08:29:01

DOYLESTOWN, Pa., March 19, 2014 /PRNewswire/ -- Novira Therapeutics, Inc., today announced that Christian S. Schade has been named Chief Executive Officer, effective March 19. Mr. Schade has more than 30 years of extensive private and public pharmaceutical and biotechnology industry experience as well as broad capital markets experience from his tenure in the investment banking industry. Prior to joining Novira he was Executive Vice President and Chief Financial Officer of Omthera...

2014-03-18 23:33:25

Rapid CYP2C19 Testing for Personalized Antiplatelet Therapy in 600-Patient Clinical Trial with Spartan Bioscience (PRWEB) March 18, 2014 Spartan Bioscience today announced the start of a 600-patient study of personalized medicine for cardiac stent patients in Germany. The study is part of a larger clinical trial entitled “Testing Responsiveness to Platelet Inhibition on Chronic Antiplatelet Treatment for Acute Coronary Syndromes Trial (TROPICAL-ACS)”. TROPICAL-ACS, led by principal...

2014-03-18 08:32:43

-- ABRAXANE plus gemcitabine approved by the TGA for the first-line treatment of metastatic pancreatic cancer MELBOURNE, Australia, March 18, 2014 /PRNewswire/ -- Australian biopharmaceutical company Specialised Therapeutics Australia (STA) is pleased to announce that ABRAXANE(®) (nanoparticle albumin-bound paclitaxel) in combination with gemcitabine in now approved by the Therapeutic Goods Administration (TGA) for the first-line treatment of metastatic pancreatic cancer. The TGA approved...


Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related